LeadingBiotech Officially Announces Its New Ambassador Committee

Monday, November 19, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

The select group of experts will advise on overall strategy and pinpoint important trends--helping to better serve its community of senior-level leaders.

BOSTON, Nov. 19, 2018 /PRNewswire-PRWeb/ -- LeadingBiotech (formerly Boston Biotech Conferences), creator of exclusive

peer-to-peer CEO meetings for the biotech community, announces its new Ambassador Committee.

The committee is part of the recently appointed leadership team at LeadingBiotech. Along with CEO, Wendy Nelson Ph.D., and Chairman Bob Buderi, this select group of experts will have an influential role by advising on overall strategy and pinpointing important trends—helping to better serve its community of senior-level leaders.

Meet the LeadingBiotech Ambassador Committee:

Brian Gallagher Jr. Ph.D. Partner, Abingworth Gallagher has over 20 years of investing, business development, operational and R&D experience in both biotechnology and pharmaceutical companies. Prior to joining Abingworth in October, he was a Partner for SR One, the venture arm of GSK, for 8 years. Gallagher received his Ph.D. in Organic Chemistry from University of Michigan.

"I'm excited to work with the LeadingBiotech team as they take the preeminent biotech conference series with a global reach to the next level." – Brian Gallagher Jr. Ph.D.

Carol Gallagher Pharm.D. Partner, New Enterprise Associates Gallagher has nearly 30 years of experience in commercial, drug development, and business roles in both large and small biopharma companies. Prior to joining NEA in 2014, she spent several years as an independent board director. From 2008-2011, she was CEO of Calistoga Pharmaceuticals which was acquired by Gilead. Gallagher received her Doctor of Pharmacy from the University of Kentucky.

Michael Gilman Ph.D. Chairman and CEO, Arrakis Therapeutics Gilman has made over 30 years of contributions in the biotech and biopharma fields. Prior to joining Arrakis Therapeutics in 2016, he was Founder and Chief Executive of Padlock Therapeutics, a venture-funded company focused on autoimmune disease. Gilman received his S.B. in Life Sciences from Massachusetts Institute of Technology and his Ph.D. in Biochemistry from University of California, Berkeley.

Rachel Haurwitz Ph.D. President & CEO, Caribou Biosciences Haurwitz is the co-founder of Caribou Biosciences and has been President and CEO since its inception in 2011. She has a research background in CRISPR-Cas biology and is also a co-founder of Intellia Therapeutics. Haurwitz received her A.B. in Biological Sciences from Harvard College and her Ph.D. in Molecular and Cell Biology from Universtiy of California, Berkeley.

Mary Lynne Hedley Ph.D. President & Chief Operating Officer, TESARO Hedley has over 20 years of experience in the biotech and biopharma fields. Prior to being co-founder of TESARO in 2010, she served as Executive Vice President of Operations and Chief Scientific Officer of Abraxis BioScience. Hedley completed two consecutive postdoctoral fellowships at Harvard University and received her B.S. in Microbiology from Purdue University and her Ph.D. in Immunology from University of Texas, Southwestern Medical Center.

Susan Windham-Bannister Ph.D. President & CEO, Biomedical Growth Strategies LLC Windham-Bannister has spent over 40 years advising major biopharma companies on strategic decisions essential for market access, growth optimization, and portfolio management. Prior to joining Biomedical Growth Strategies LLC in 2015, she served as founding President and CEO of the $1 billion Massachusetts Life Sciences Initiative. Windham-Bannister received her B.A. from Wellesley College, her Ph.D. in Health Policy and Management from Florence Heller School at Brandeis University, and her Sc.D. from Worcester Polytechnic Institute.

The Ambassador Committee is working with Nelson and Buderi to implement several exciting changes—making LeadingBiotech a premier networking and content-rich event series. "I'm thrilled to have the support and advice of such an esteemed group of Ambassadors as we work to bring our new brand LeadingBiotech forward!" – Wendy Nelson Ph.D.

Join us at the inaugural LeadingBiotech event, East/West CEO, to engage with some of the Ambassadors and other senior-level peers! The event is on January 5-6, 2019 at the Four Seasons Hotel in San Francisco, CA. Learn more.

Contact: LeadingBiotech Suzanne Carroll suzanne@leadingbiotech.com +1 857-504-6707

 

SOURCE LeadingBiotech



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store